Keyword: Ariad Pharmaceuticals

Merrimack poaches Ariad CMO after shake-ups for both companies

Following a major reorganization earlier this year that saw it sell off its marketed med and revert back to being a clinical-stage biotech, Merrimack is making major changes in its executive team, announcing today that former Ariad chief medical officer Sergio Santillana, M.D., will be its new medical lead.